Although the radiotracer uptake in the tumor with intravenous injection of DOX was slightly lower than that in the group with intratumoral injection of DOX, which resulted from the relatively lower expression level of activated caspase-3 in the former group, the tracer uptake ratio in DOX-treated versus untreated tumors was still at an acceptable level. This evidence concerns the gene CASP3 and neoplasm.